Segment Information (Tables)

12 Months Ended

Dec. 31, 2013

Segment Information

Schedule of revenues, cost of revenues and gross profit for each commercial product

Revenues, cost of revenues and gross profit for each of our commercial products are as follows (in thousands):

	Remodulin		Tyvaso		Adcirca		Total
Year Ended December 31, 2013
Revenues	$	491,179	$	438,793	$	176,972	$	1,106,944
Cost of revenues		59,314		60,831		10,982		131,127
Gross profit	$	431,865	$	377,962	$	165,990	$	975,817
Year Ended December 31, 2012
Revenues	$	457,969	$	325,614	$	122,540	$	906,123
Cost of revenues		57,618		53,825		7,854		119,297
Gross profit	$	400,351	$	271,789	$	114,686	$	786,826
Year Ended December 31, 2011
Revenues	$	430,132	$	240,382	$	70,580	$	741,094
Cost of revenues		52,329		31,934		4,641	$	88,904
Gross profit	$	377,803	$	208,448	$	65,939	$	652,190

Schedule of net revenues from external customers by geographic area

Net revenues from external customers by geographic area are as follows (in thousands):

Year Ended December 31,	2013		2012		2011
United States	$	1,032,435	$	846,611	$	676,967
Rest-of-World(1)		84,549		69,465		66,216
Total	$	1,116,984	$	916,076	$	743,183

(1)

Primarily Europe.

Schedule of long-lived assets (property, plant and equipment) located by geographic area

Long-lived assets (property, plant and equipment) located by geographic area are as follows (in thousands):

Year Ended December 31,	2013		2012		2011
United States	$	442,673	$	425,585	$	345,153
Rest-of-World(1)		22,277		28,100		20,893
Total	$	464,950	$	453,685	$	366,046

(1)

Facilities principally located in the United Kingdom.